These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9476504)

  • 1. Prophylaxis of fungal infections.
    Schuler US; Haag C
    Mycoses; 1997; 40 Suppl 2():41-4. PubMed ID: 9476504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prophylaxis against mycoses in neutropenic patients].
    Arning M; Aul C
    Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO; Bowman JL; Penzak SR
    Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole.
    Oliveira JS; Kerbauy FR; Colombo AL; Bahia DM; Pinheiro GS; Silva MR; Ribeiro MS; Raineri G; Kerbauy J
    Braz J Med Biol Res; 2002 Jul; 35(7):789-98. PubMed ID: 12131918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal prophylaxis during neutropenia and immunodeficiency.
    Lortholary O; Dupont B
    Clin Microbiol Rev; 1997 Jul; 10(3):477-504. PubMed ID: 9227863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylaxis and therapy of fungal infections with fluconazole in patients after bone marrow transplantation].
    Quabeck K; Müller KD; Beelen DW; Dermoumi H; Kölbel M; Kraft J; Schaefer UW
    Mycoses; 1990; 33 Suppl 1():19-26. PubMed ID: 2101860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal prophylaxis in bone marrow transplantation.
    Milliken ST; Powles RL
    Rev Infect Dis; 1990; 12 Suppl 3():S374-9. PubMed ID: 2184515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
    Salavert-Lletí M; Zaragoza-Crespo R
    Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal prophylaxis in bone marrow transplant.
    Lam HH; Althaus BL
    Ann Pharmacother; 1995 Sep; 29(9):921-4. PubMed ID: 8547742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
    Playford EG; Webster AC; Sorrell TC; Craig JC
    J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal.
    Uzun O; Anaissie EJ
    Blood; 1995 Sep; 86(6):2063-72. PubMed ID: 7662953
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy.
    MacMillan ML; Goodman JL; DeFor TE; Weisdorf DJ
    Am J Med; 2002 Apr; 112(5):369-79. PubMed ID: 11904111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.
    Morgenstern GR; Prentice AG; Prentice HG; Ropner JE; Schey SA; Warnock DW
    Br J Haematol; 1999 Jun; 105(4):901-11. PubMed ID: 10554799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal prophylaxis in immunocompromised hosts.
    Reents S; Goodwin SD; Singh V
    Ann Pharmacother; 1993 Jan; 27(1):53-60. PubMed ID: 8431623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole versus oral polyenes in the prophylaxis of immunocompromised patients: a cost-minimization analysis.
    Wakerly L; Craig AM; Malek M; Hoffmeyer U; Lloyd A; Valette F; Phillips R; Zabihollah M
    J Hosp Infect; 1996 May; 33(1):35-48. PubMed ID: 8738200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
    Playford EG; Webster AC; Sorrell TC; Craig JC
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004920. PubMed ID: 16437504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal prophylaxis during neutropenia or allogeneic bone marrow transplantation: what is the state of the art? Ad HOC Working Group.
    Denning DW; Donnelly JP; Hellreigel KP; Ito J; Martino P; van't Wout JW
    Chemotherapy; 1992; 38 Suppl 1():43-9. PubMed ID: 1611930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.